XBIT Projected Dividend Yield
XBiotech Inc ( NASDAQ : XBIT )XBiotech is a biopharmaceutical company that discovers and develops True Human™ monoclonal antibodies for treating a variety of diseases. Co. has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. An area of medical focus for Co. are therapies that block a substance naturally produced by body, known as interleukin-1 alpha, that mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting and inflammation. Co.'s product development includes: Natrunix program, which is for the indication of pancreatic cancer and rheumatoid arthritis, and Hutrukin program, which is for the indication of stroke. 13 YEAR PERFORMANCE RESULTS |
XBIT Dividend History Detail XBIT Dividend News XBIT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2021 |
Jul 06, 2021 |
Jul 15, 2021 |
Jul 16, 2021 |
Jul 23, 2021 |
2.4700 |
2021 Total: |
2.4700 |